Immunotherapies targeting tumor vasculature: challenges and opportunities

Angiogenesis is a hallmark of cancer biology, and neoadjuvant therapies targeting either tumor vasculature or VEGF signaling have been developed to treat solid malignant tumors. However, these therapies induce complete vascular depletion leading to hypoxic niche, drug resistance, and tumor recurrenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dianat-Moghadam, Hassan, Nedaeinia, Reza, Keshavarz, Mohsen, Azizi, Mehdi, Kazemi, Mohammad, Salehi, Rasoul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506263/
https://www.ncbi.nlm.nih.gov/pubmed/37727791
http://dx.doi.org/10.3389/fimmu.2023.1226360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506263/
https://www.ncbi.nlm.nih.gov/pubmed/37727791
http://dx.doi.org/10.3389/fimmu.2023.1226360

Ejemplares similares